Abstract
Background: Single-centered studies show increased number of acute pancreatitis (AP) in children. Here, the Pediatric Section of the Hungarian Pancreatic Study Group introduces an international observational clinical trial (APPLE) to collect a critical mass of clinical data and biomedical research samples in a uniform prospective manner. Summary: The APPLE-R is for patients under 18 years of age with a history of pancreatitis. The study primarily provides information on possible genetic variants behind the disease and their impact on the prognosis. The APPLE-P is for patients under 18 years of age with a diagnosis of AP. Children with AP diagnosed based on the fulfillment of ‘2 out of 3' of the Atlanta criteria will be selected. This subtrial requests detailed information from the medical history, etiology, complains and symptoms, physical examinations, laboratory parameters, imaging, immediate therapy at admission and complications of the disease. The APPLE trial has been registered at the ISRCTN registry and has received the relevant ethical approval. The study is open for all pediatric centers throughout the world. Key Message: This is the first worldwide study tracking earlier (APPLE-R) and ongoing episodes (APPLE-P) of pancreatitis.
Journal Section:
Original Paper
References
1.
Lopez MJ: The changing incidence of acute pancreatitis in children: a single-institution perspective. J Pediatr 2002;140:622-624.
2.
Morinville VD, Barmada MM, Lowe ME: Increasing incidence of acute pancreatitis at an American pediatric tertiary care center: is greater awareness among physicians responsible? Pancreas 2010;39:5-8.
[PubMed]
3.
Nydegger A, Heine RG, Ranuh R, Gegati-Levy R, Crameri J, Oliver MR: Changing incidence of acute pancreatitis: 10-year experience at the Royal Children's Hospital, Melbourne. J Gastroenterol Hepatol 2007;22:1313-1316.
[PubMed]
4.
Park A, Latif SU, Shah AU, Tian J, Werlin S, Hsiao A, Pashankar D, Bhandari V, Nagar A, Husain SZ: Changing referral trends of acute pancreatitis in children: a 12-year single-center analysis. J Pediatr Gastroenterol Nutr 2009;49:316-322.
[PubMed]
5.
Sánchez-Ramírez CA, Larrosa-Haro A, Flores-Martínez S, Sánchez-Corona J, Villa-Gómez A, Macías-Rosales R: Acute and recurrent pancreatitis in children: etiological factors. Acta Paediatr 2007;96:534-537.
[PubMed]
6.
Werlin SL, Kugathasan S, Frautschy BC: Pancreatitis in children. J Pediatr Gastroenterol Nutr 2003;37:591-595.
[PubMed]
7.
Pant C, Deshpande A, Olyaee M, Anderson MP, Bitar A, Steele MI, Bass PF 3rd, Sferra TJ: Epidemiology of acute pancreatitis in hospitalized children in the United States from 2000-2009. PLoS One 2014;9:e95552.
[PubMed]
8.
Meyer A, Coffey MJ, Oliver MR, Ooi CY: Contrasts and comparisons between childhood and adult onset acute pancreatitis. Pancreatology 2013;13:429-435.
[PubMed]
9.
Párniczky A, Czakó L, Dubravcsik Z, Farkas G, Hegyi P, Hritz I, Kelemen D, Morvay Z, Oláh A, Pap Á, Sahin-Tóth M, Szabó F, Szentkereszti Z, Szmola R, Takács T, Tiszlavicz L, Veres G, Szücs Á, Lásztity N; Magyar Hasnyálmirigy Munkacsoport, Hungarian Pancreatic Study Group: [Pediatric pancreatitis. Evidence based management guidelines of the Hungarian Pancreatic Study Group]. Orv Hetil 2015;156:308-325.
[PubMed]
10.
Morinville VD, Husain SZ, Bai H, Barth B, Alhosh R, Durie PR, Freedman SD, Himes R, Lowe ME, Pohl J, Werlin S, Wilschanski M, Uc A; INSPPIRE Group: Definitions of pediatric pancreatitis and survey of present clinical practices. J Pediatr Gastroenterol Nutr 2012;55:261-265.
[PubMed]
11.
Hritz I, Czakó L, Dubravcsik Z, Farkas G, Kelemen D, Lásztity N, Morvay Z, Oláh A, Pap Á, Párniczky A, Sahin-Tóth M, Szentkereszti Z, Szmola R, Szücs Á, Takács T, Tiszlavicz L, Hegyi P; Magyar Hasnyálmirigy Munkacsoport, Hungarian Pancreatic Study Group: [Acute pancreatitis. Evidence-based practice guidelines, prepared by the Hungarian Pancreatic Study Group]. Orv Hetil 2015;156:244-261.
[PubMed]
12.
Dubravcsik Z, Farkas G, Hegyi P, Hritz I, Kelemen D, Lásztity N, Morvay Z, Oláh A, Pap Á, Párniczky A, Sahin-Tóth M, Szentkereszti Z, Szmola R, Takács T, Tiszlavicz L, Szücs Á, Czakó L; Magyar Hasnyálmirigy Munkacsoport, Hungarian Pancreatic Study Group: [Autoimmune pancreatitis. Evidence based management guidelines of the Hungarian Pancreatic Study Group]. Orv Hetil 2015;156:292-307.
[PubMed]
13.
Szmola R, Farkas G, Hegyi P, Czakó L, Dubravcsik Z, Hritz I, Kelemen D, Lásztity N, Morvay Z, Oláh A, Párniczky A, Rubovszky G, Sahin-Tóth M, Szentkereszti Z, Szücs Á, Takács T, Tiszlavicz L, Pap Á; Magyar Hasnyálmirigy Munkacsoport, Hungarian Pancreatic Study Group: [Pancreatic cancer. Evidence based management guidelines of the Hungarian Pancreatic Study Group]. Orv Hetil 2015;156:326-339.
[PubMed]
14.
Hritz I, Hegyi P: Early Achievable Severity (EASY) index for simple and accurate expedite risk stratification in acute pancreatitis. J Gastrointestin Liver Dis 2015;24:177-182.
[PubMed]
15.
Dubravcsik Z, Madácsy L, Gyökeres T, Vincze Á, Szepes Z, Hegyi P, Hritz I, Szepes A; Hungarian Pancreatic Study Group: Preventive pancreatic stents in the management of acute biliary pancreatitis (PREPAST trial): pre-study protocol for a multicenter, prospective, randomized, interventional, controlled trial. Pancreatology 2015;15:115-123.
[PubMed]
16.
Németh BC, Sahin-Tóth M: Human cationic trypsinogen (PRSS1) variants and chronic pancreatitis. Am J Physiol Gastrointest Liver Physiol 2014;306:G466-G473.
[PubMed]
17.
Derikx MH, Kovacs P, Scholz M, Masson E, Chen JM, Ruffert C, Lichtner P, Te Morsche RH, Cavestro GM; PanEuropean Working Group on Alcoholic Chronic Pancreatitis Members and Collaborators, Férec C, Drenth JP, Witt H, Rosendahl J: Polymorphisms at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with alcoholic and non-alcoholic chronic pancreatitis in a European replication study. Gut 2015;64:1426-1433.
[PubMed]
18.
Schnúr A, Beer S, Witt H, Hegyi P, Sahin-Tóth M: Functional effects of 13 rare PRSS1 variants presumed to cause chronic pancreatitis. Gut 2014;63:337-343.
[PubMed]
19.
Joergensen MT, Geisz A, Brusgaard K, Schaffalitzky de Muckadell OB, Hegyi P, Gerdes AM, Sahin-Toth M: Intragenic duplication: a novel mutational mechanism in hereditary pancreatitis. Pancreas 2011;40:540-546.
[PubMed]
20.
Rosendahl J, Witt H, Szmola R, Bhatia E, Ozsvari B, Landt O, Schulz HU, Gress TM, Pfutzer R, Lohr M, Kovacs P, Bluher M, Stumvoll M, Choudhuri G, Hegyi P, te Morsche RH, Drenth JP, Truninger K, Macek M Jr, Puhl G, Witt U, Schmidt H, Buning C, Ockenga J, Kage A, Groneberg DA, Nickel R, Berg T, Wiedenmann B, Bodeker H, Keim V, Mossner J, Teich N, Sahin-Toth M: Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet 2008;40:78-82.
[PubMed]
21.
Geisz A, Hegyi P, Sahin-Toth M: Robust autoactivation, chymotrypsin C independence and diminished secretion define a subset of hereditary pancreatitis-associated cationic trypsinogen mutants. FEBS J 2013;280:2888-2899.
[PubMed]
22.
Sharer N, Schwarz M, Malone G, Howarth A, Painter J, Super M, Braganza J: Mutations of the cystic fibrosis gene in patients with chronic pancreatitis. N Engl J Med 1998;339:645-652.
[PubMed]
23.
Masson E, Chen JM, Audrezet MP, Cooper DN, Ferec C: A conservative assessment of the major genetic causes of idiopathic chronic pancreatitis: data from a comprehensive analysis of PRSS1, SPINK1, CTRC and CFTR genes in 253 young French patients. PLoS One 2013;8:e73522.
[PubMed]
24.
Witt H, Luck W, Hennies HC, Classen M, Kage A, Lass U, Landt O, Becker M: Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis. Nat Genet 2000;25:213-216.
[PubMed]
25.
Witt H, Beer S, Rosendahl J, Chen JM, Chandak GR, Masamune A, Bence M, Szmola R, Oracz G, Macek M Jr, Bhatia E, Steigenberger S, Lasher D, Buhler F, Delaporte C, Tebbing J, Ludwig M, Pilsak C, Saum K, Bugert P, Masson E, Paliwal S, Bhaskar S, Sobczynska-Tomaszewska A, Bak D, Balascak I, Choudhuri G, Nageshwar Reddy D, Rao GV, Thomas V, Kume K, Nakano E, Kakuta Y, Shimosegawa T, Durko L, Szabo A, Schnur A, Hegyi P, Rakonczay Z Jr, Pfutzer R, Schneider A, Groneberg DA, Braun M, Schmidt H, Witt U, Friess H, Algul H, Landt O, Schuelke M, Kruger R, Wiedenmann B, Schmidt F, Zimmer KP, Kovacs P, Stumvoll M, Bluher M, Muller T, Janecke A, Teich N, Grutzmann R, Schulz HU, Mossner J, Keim V, Lohr M, Ferec C, Sahin-Toth M: Variants in CPA1 are strongly associated with early onset chronic pancreatitis. Nat Genet 2013;45:1216-1220.
[PubMed]
26.
Ragvin A, Fjeld K, Weiss FU, Torsvik J, Aghdassi A, Mayerle J, Simon P, Njolstad PR, Lerch MM, Johansson S, Molven A: The number of tandem repeats in the carboxyl-ester lipase (CEL) gene as a risk factor in alcoholic and idiopathic chronic pancreatitis. Pancreatology 2013;13:29-32.
[PubMed]
27.
Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG, Vege SS; Acute Pancreatitis Classification Working Group: Classification of acute pancreatitis - 2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013;62:102-111.
[PubMed]
28.
Abu-El-Haija M, Lin TK, Palermo J: Update to the management of pediatric acute pancreatitis: highlighting areas in need of research. J Pediatr Gastroenterol Nutr 2014;58:689-693.
[PubMed]
29.
Bai HX, Lowe ME, Husain SZ: What have we learned about acute pancreatitis in children? J Pediatr Gastroenterol Nutr 2011;52:262-270.
[PubMed]
30.
Joergensen M, Brusgaard K, Cruger DG, Gerdes AM, Schaffalitzky de Muckadell OB: Incidence, etiology and prognosis of first-time acute pancreatitis in young patients: a population-based cohort study. Pancreatology 2010;10:453-461.
[PubMed]
31.
Lucidi V, Alghisi F, Dall'Oglio L, D'Apice MR, Monti L, De Angelis P, Gambardella S, Angioni A, Novelli G: The etiology of acute recurrent pancreatitis in children: a challenge for pediatricians. Pancreas 2011;40:517-521.
[PubMed]
32.
Park AJ, Latif SU, Ahmad MU, Bultron G, Orabi AI, Bhandari V, Husain SZ: A comparison of presentation and management trends in acute pancreatitis between infants/toddlers and older children. J Pediatr Gastroenterol Nutr 2010;51:167-170.
[PubMed]
33.
Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Localio SA: Objective early identification of severe acute pancreatitis. Am J Gastroenterol 1974;61:443-451.
[PubMed]
34.
Ranson JH: Etiological and prognostic factors in human acute pancreatitis: a review. Am J Gastroenterol 1982;77:633-638.
[PubMed]
35.
Blamey SL, Imrie CW, O'Neill J, Gilmour WH, Carter DC: Prognostic factors in acute pancreatitis. Gut 1984;25:1340-1346.
[PubMed]
36.
Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-829.
[PubMed]
37.
Suzuki M, Fujii T, Takahiro K, Ohtsuka Y, Nagata S, Shimizu T: Scoring system for the severity of acute pancreatitis in children. Pancreas 2008;37:222-223.
[PubMed]
38.
Lautz TB, Chin AC, Radhakrishnan J: Acute pancreatitis in children: spectrum of disease and predictors of severity. J Pediatr Surg 2011;46:1144-1149.
[PubMed]
39.
Fabre A, Petit P, Gaudart J, Mas E, Vial J, Olives JP, Sarles J: Severity scores in children with acute pancreatitis. J Pediatr Gastroenterol Nutr 2012;55:266-267.
[PubMed]
40.
DeBanto JR, Goday PS, Pedroso MR, Iftikhar R, Fazel A, Nayyar S, Conwell DL, Demeo MT, Burton FR, Whitcomb DC, Ulrich CD 2nd, Gates LK Jr; Midwest Multicenter Pancreatic Study Group: Acute pancreatitis in children. Am J Gastroenterol 2002;97:1726-1731.
[PubMed]
41.
Uc A: Predicting the severity of pediatric acute pancreatitis: are we there yet? J Pediatr Gastroenterol Nutr 2013;56:584-585.
[PubMed]
© 2015 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2015
You do not currently have access to this content.
